Nettsider med emneord «cancer»

There is great interest in artificial intelligence (AI) in health care. A recent paper in Gastroenterology discusses important issues when introducing new technology in medicine.

The immune system protects us against infection and cancer but may also overreact and cause autoimmune disease. Knowledge of molecular mechanisms regulating immune cell activation and control is needed to understand how autoimmune diseases may be prevented or treated.

The immunology group combines proteomics with molecular and cellular biology to investigate the regulation of innate and adaptive immunity, and pathogenic mechanisms involved in autoimmune disease and cancer.

In an essay published this week on the World Economic Forum's News Agenda, UiO researcher Ishita Barua explains why we should look to Finland when planning for future success.

The torpedoes reside in specific cells of the innate immune system. These cells could be the next breakthrough in cancer treatment.

Dr. Yuichi Mori, postdoctoral fellow at Clinical effectiveness research group, receives the prestigeous EU Grant the Marie Skłodowska-Curie Actions fellowship. 

Professor Johanna Olweus has been selected for the final of the Cancer Grand Challenges as part of a global research team. If successful, the team hopes to contribute in giving cancer patients new therapies.

Risk of colorectal cancer in inflammatory bowel disease

– a multinational cohort study.

Researchers have identified a novel immunotherapy for acute myeloid leukemia (AML). Immune cells are programmed to recognize a mutation found in leukemia patients. The results provide hope for new and effective treatment for the most common form of leukemia in adults.